| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 11 | +54.55% | -0.71% | -0.46% | -0.25% | +1.79% | — |
| 14d | 11 | +54.55% | -3.13% | -0.06% | -3.07% | +1.38% | — |
| 30d | 11 | +45.45% | -0.87% | -0.00% | -0.86% | +2.44% | — |
| 60d | 11 | +45.45% | -1.43% | +0.64% | -2.07% | -2.95% | — |
| 90d | 11 | +54.55% | -1.59% | +3.31% | -2.95% | -1.83% | — |
| 180d | 11(1 pending) | +70.00% | +0.73% | +9.14% | -8.41% | -18.49% | — |
| 1y | 11(1 pending) | +70.00% | -14.64% | +16.36% | -31.00% | -37.87% | — |
| 2y | 11(1 pending) | +80.00% | -13.11% | +32.03% | -45.14% | -71.03% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| VNDA VANDA PHARMACEUTICALS INC. | SALE SVP, Chief Marketing Officer | 30,800 | $8.27 | $254.6K | 333,469 | Mar 2, 2026 | Mar 4, 2026 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 125,000 | — | — | 364,269 | Feb 18, 2026 | Feb 19, 2026 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | SALE SVP, Chief Marketing Officer | 15,520 | $4.76 | $73.9K | 239,269 | Mar 1, 2025 | Mar 4, 2025 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 125,000 | — | — | 254,789 | Feb 18, 2025 | Feb 20, 2025 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | SALE SVP, Chief Marketing Officer | 9,229 | $4.21 | $38.8K | 129,789 | Mar 5, 2024 | Mar 6, 2024 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | SALE SVP, Chief Marketing Officer | 7,498 | $4.41 | $33.1K | 139,018 | Mar 4, 2024 | Mar 6, 2024 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 32,700 | — | — | 146,516 | Feb 16, 2024 | Feb 21, 2024 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | SALE SVP, Chief Marketing Officer | 3,724 | $5.84 | $21.7K | 113,816 | Aug 21, 2023 | Aug 23, 2023 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | SALE SVP, Chief Marketing Officer | 4,113 | $6.32 | $26.0K | 117,540 | Mar 3, 2023 | Mar 6, 2023 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | SALE SVP, Chief Marketing Officer | 7,720 | $6.23 | $48.1K | 121,653 | Mar 2, 2023 | Mar 6, 2023 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 32,700 | — | — | 129,373 | Feb 16, 2023 | Feb 21, 2023 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 77,500 | — | — | 77,500 | Feb 16, 2023 | Feb 21, 2023 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | SALE SVP, Chief Marketing Officer | 3,605 | $10.27 | $37.0K | 96,673 | Aug 22, 2022 | Aug 23, 2022 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | SALE SVP, Chief Marketing Officer | 6,974 | $11.19 | $78.1K | 100,278 | Mar 2, 2022 | Mar 2, 2022 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 77,500 | — | — | 77,500 | Feb 28, 2022 | Mar 2, 2022 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 32,700 | — | — | 107,252 | Feb 28, 2022 | Mar 2, 2022 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | SALE SVP, Chief Marketing Officer | 3,650 | $15.39 | $56.2K | 74,552 | Aug 20, 2021 | Aug 23, 2021 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | SALE SVP, Chief Marketing Officer | 3,888 | $18.45 | $71.7K | 78,202 | Mar 2, 2021 | Mar 3, 2021 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 61,200 | — | — | 61,200 | Feb 24, 2021 | Feb 26, 2021 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 25,800 | — | — | 82,090 | Feb 24, 2021 | Feb 26, 2021 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | SALE SVP, Chief Marketing Officer | 3,710 | $11.08 | $41.1K | 56,290 | Aug 20, 2020 | Aug 21, 2020 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 60,000 | Feb 26, 2020 | Feb 28, 2020 ↗ | View → |
| VNDA VANDA PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 70,000 | — | — | 70,000 | Feb 26, 2020 | Feb 28, 2020 ↗ | View → |